Comments

Neurocrine Biosciences

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NBIXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$136.53

-0.46-0.34%

At close: -

$137.24

0.710.52%

After Hours: 4:00 PM EDT

Neurocrine Biosciences (NBIX) Forecast

News Earnings Neurocrine Biosciences (NBIX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Neurocrine Biosciences (NASDAQ:NBIX) Stock Quotes, Forecast and News Summary

Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.

Open	$137.51
Close	$136.53
Volume / Avg.	341.45K / 961.95K
Day Range	$135.84 - $138.12
52 Wk Range	110.95 - 157.98
Market Cap	$13.90B
P/E Ratio	36.53
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	4.52%
Days to Cover	3.78

Recent News

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

The top-performing stocks last week were TEVA, KVYO, DRI, DOCS, BIRK, JBL, NBIX, GME, RDY, and LI. Did you have any of them in your portfolio?

Lekha Gupta

Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential

Neurocrine's Crenessity receives FDA approval as a groundbreaking adjunctive treatment for classic CAH, offering a novel approach to hormone regulation.

Vandana Singh

Screening For Black Friday Bargains In The Stock Market

David Pinsen

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$137.51
Close	$136.53
Volume / Avg.	341.45K / 961.95K
Day Range	$135.84 - $138.12
52 Wk Range	110.95 - 157.98
Market Cap	$13.90B
P/E Ratio	36.53
Dividend Yield	-
Exchange	NASDAQ
RSI	67
Short Interest	4.52%
Days to Cover	3.78

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $164.00.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $137.24 last updated December 24, 2024 at 4:00 PM EST.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.